Dimensional Fund Advisors LP Sells 190,354 Shares of Prestige Consumer Healthcare Inc. $PBH

Key Points

• Dimensional Fund Advisors LP reduced its stake in Prestige Consumer Healthcare by 6.5%, holding approximately 2.72 million shares worth $233.55 million at the end of the first quarter.
• Analysts have mixed views on Prestige Consumer Healthcare, with rating adjustments including a downgrade to "hold" by Wall Street Zen and target price reductions from Canaccord Genuity, now sitting at $100.
• Prestige Consumer Healthcare's latest earnings report revealed EPS of $0.95, missing estimates, and a revenue decline of 6.6% year-over-year at $249.53 million.

Dimensional Fund Advisors LP lowered its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 6.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,716,712 shares of the company's stock after selling 190,354 shares during the quarter. Dimensional Fund Advisors LP owned 5.48% of Prestige Consumer Healthcare worth $233,551,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Fox Run Management L.L.C. purchased a new stake in Prestige Consumer Healthcare in the first quarter worth approximately $254,000. Sei Investments Co. boosted its holdings in Prestige Consumer Healthcare by 3.2% in the first quarter. Sei Investments Co. now owns 215,271 shares of the company's stock worth $17,051,000 after purchasing an additional 6,681 shares during the last quarter. Russell Investments Group Ltd. boosted its holdings in Prestige Consumer Healthcare by 2.0% in the first quarter. Russell Investments Group Ltd. now owns 28,115 shares of the company's stock worth $2,417,000 after purchasing an additional 561 shares during the last quarter. Resona Asset Management Co. Ltd. boosted its holdings in Prestige Consumer Healthcare by 2.3% in the first quarter. Resona Asset Management Co. Ltd. now owns 9,105 shares of the company's stock worth $783,000 after purchasing an additional 203 shares during the last quarter. Finally, Informed Momentum Co LLC purchased a new stake in Prestige Consumer Healthcare in the first quarter worth approximately $3,559,000. Hedge funds and other institutional investors own 99.95% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on PBH shares. Canaccord Genuity Group dropped their target price on shares of Prestige Consumer Healthcare from $105.00 to $100.00 and set a "buy" rating on the stock in a report on Friday, August 8th. Wall Street Zen cut shares of Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a report on Saturday, August 9th. Finally, Royal Bank Of Canada upgraded shares of Prestige Consumer Healthcare to a "hold" rating in a research note on Thursday, May 8th. Three research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to MarketBeat.com, Prestige Consumer Healthcare has a consensus rating of "Moderate Buy" and a consensus target price of $93.33.

Prestige Consumer Healthcare Stock Performance

Shares of Prestige Consumer Healthcare stock traded up $1.3050 on Friday, hitting $66.7550. 542,270 shares of the company's stock were exchanged, compared to its average volume of 583,477. The company has a 50-day simple moving average of $75.29 and a 200-day simple moving average of $81.22. The stock has a market capitalization of $3.29 billion, a PE ratio of 15.67, a PEG ratio of 2.11 and a beta of 0.43. Prestige Consumer Healthcare Inc. has a 1 year low of $62.95 and a 1 year high of $90.04. The company has a debt-to-equity ratio of 0.55, a quick ratio of 2.99 and a current ratio of 4.38.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.95 earnings per share for the quarter, missing the consensus estimate of $1.01 by ($0.06). The business had revenue of $249.53 million for the quarter, compared to analysts' expectations of $260.71 million. Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%.The company's revenue was down 6.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.90 EPS. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.500-4.580 EPS. As a group, equities analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.